Polyrizon Ltd. (NASDAQ:PLRZ) Short Interest Up 1,102.1% in December

Polyrizon Ltd. (NASDAQ:PLRZ) was the target of a significant increase in short interest in December. As of December 15th, there was short interest totaling 176,028 shares, an increase of 1,102.1% from the November 30th total of 14,643 shares. Based on an average daily trading volume, of 16,817,222 shares, the days-to-cover ratio is presently 0.0 days. Currently, 16.9% of the shares of the company are sold short. Currently, 16.9% of the shares of the company are sold short. Based on an average daily trading volume, of 16,817,222 shares, the days-to-cover ratio is presently 0.0 days.

Polyrizon Price Performance

NASDAQ:PLRZ opened at $7.61 on Friday. Polyrizon has a 12-month low of $2.88 and a 12-month high of $4,200.00. The firm has a 50-day moving average price of $6.95 and a 200 day moving average price of $6.41.

Analyst Ratings Changes

A number of brokerages have commented on PLRZ. Weiss Ratings reiterated a “sell (e+)” rating on shares of Polyrizon in a research report on Wednesday, October 8th. Wall Street Zen upgraded Polyrizon from a “strong sell” rating to a “hold” rating in a research note on Saturday, September 20th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock has a consensus rating of “Sell”.

About Polyrizon

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.